ArticleACG case reports journal2015
A Case of Severe Sprue-Like Enteropathy Associated With Valsartan.
Article in ACG case reports journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 62 citations in OpenAlex.
- Olmesartan-associated enteropathy presenting with metabolic acidosis and acute kidney injury requiring hemodialysis: a rechallenge-confirmed case.CEN case reports · 2026Article
- Diagnostic Challenges in Enteropathies: A Histopathological Review.Diagnostics (Basel, Switzerland) · 2025Review
- A Rare Case of Olmesartan-Associated Enteropathy Successfully Managed With Steroid Taper.Cureus · 2023Article
- Coeliac disease enteropathy and symptoms may be aggravated by angiotensin receptor blockers in patients on a gluten-free diet.United European gastroenterology journal · 2021Article
- An elderly woman with severe enteritis mimicking infectious enteritis.Intestinal research · 2021Article
- Clinical factors related to severe enterocolitis after adjuvant CAPOX for colorectal cancer: a retrospective analysis.Ecancermedicalscience · 2020Article
- Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.Wiener klinische Wochenschrift · 2019Review
- Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review.Gastroenterology report · 2019Review
- Effects of Drugs and Excipients on Hydration Status.Nutrients · 2019Review
- [Chronic diarrhea with easy solution, about 3 cases].Atencion primaria · 2019Article
- Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study.The Korean journal of internal medicine · 2019Observational
- Significant Weight Loss in a Patient Taking Olmesartan: An Unusual Case Report.Current drug safety · 2019Article
- Olmesartan-associated severe gastritis and enteropathy.BMJ case reports · 2018Article
- Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy.Pharmacoepidemiology and drug safety · 2018Observational
- Rare Case of Olmesartan Induced Enteropathy.Spartan medical research journal · 2017Article
- A Case of Moderate Sprue-Like Enteropathy Associated With Telmisartan.Journal of clinical medicine research · 2017Article
- Olmesartan-associated enteropathy.Proceedings (Baylor University. Medical Center) · 2017Article
- Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.Intestinal research · 2017Article
- Sprue-Like Enteropathy Associated With Oxcarbazepine.The American journal of gastroenterology · 2016Article
- Olmesartan-induced enteropathy associated with cutaneous lesions.Clinical case reports · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Olmesartan sprue-like enteropathy is an adverse drug reaction that mimics the appearance of celiac disease and is related to the use of olmesartan. We present the case of a 71-year-old female with severe enteropathy attributed to celiac disease for 5 years that improved only after valsartan cessation. This is the first case associating valsartan with sprue-like enteropathy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.